"they have the deals so what's wrong?" the deals are worth nothing until it can be shown that they can produce repeated revenue, imho.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game